Prostate-specific Membrane Antigen PET: Therapy Response Assessment in Metastatic Prostate Cancer

Therapy Response ◽

Response Assessment ◽

Pet Therapy ◽

Therapy Response Assessment ◽

Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

BJU International ◽

10.1111/bju.15151 ◽

2020 ◽

Author(s):

Angelyn Anton ◽

Olfat Kamel Hasan ◽

Zita Ballok ◽

Patrick Bowden ◽

Anthony J. Costello ◽

...

Keyword(s):

Prostate Cancer ◽

Positron Emission Tomography ◽

Response Assessment ◽

Emission Tomography ◽

Chemohormonal Therapy ◽

Positron Emission ◽

The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer

The Journal of Urology ◽

10.1097/ju.0000000000001592 ◽

2021 ◽

Author(s):

Dennie Meijer ◽

Hilda A. de Barros ◽

Pim J. van Leeuwen ◽

Yves J. L. Bodar ◽

Henk G. van der Poel ◽

...

Keyword(s):

Prostate Cancer ◽

Positron Emission Tomography ◽

Lymph Node ◽

Positron Emission Tomography Imaging ◽

Emission Tomography ◽

Tomography Imaging ◽

Positron Emission ◽

[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy

Oncotarget ◽

10.18632/oncotarget.11653 ◽

2016 ◽

Vol 7 (39) ◽

pp. 63747-63757 ◽

Cited By ~ 3

Author(s):

Sarah M. Schwarzenböck ◽

Anna Knieling ◽

Michael Souvatzoglou ◽

Jens Kurth ◽

Katja Steiger ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Locally Advanced ◽

Therapy Response ◽

Response Assessment ◽

High Risk Prostate Cancer ◽

Pet Ct ◽

Risk Prostate Cancer ◽

Therapy Response Assessment

244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)72042-7 ◽

2012 ◽

Vol 48 ◽

pp. 75 ◽

Cited By ~ 3

Author(s):

D. Petrylak ◽

P. Kantoff ◽

A. Mega ◽

J. Stephenson ◽

N. Vogelzang ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Antibody Drug Conjugate ◽

Phase 1 Trial ◽

Castration Resistant ◽

Antigen Antibody ◽

Specific Membrane ◽

Antibody Drug

Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-0826 ◽

2005 ◽

Vol 11 (20) ◽

pp. 7454-7461 ◽

Cited By ~ 84

Author(s):

Michael J. Morris ◽

Chaitanya R. Divgi ◽

Neeta Pandit-Taskar ◽

Maria Batraki ◽

Nyasha Warren ◽

...

Keyword(s):

Prostate Cancer ◽

Pilot Trial ◽

Indium 111 ◽

Antigen Antibody ◽

68Ga-Labeled Anti–Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000001158 ◽

2016 ◽

Vol 41 (5) ◽

pp. 423-425 ◽

Cited By ~ 5

Author(s):

Carl Diedrich Schlenkhoff ◽

Florian Gaertner ◽

Markus Essler ◽

Stefan Hauser ◽

Hojjat Ahmadzadehfar

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Therapy Response ◽

Androgen Deprivation ◽

Antigen Peptide ◽

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer

European Urology Oncology ◽

10.1016/j.euo.2018.03.010 ◽

2018 ◽

Vol 1 (1) ◽

pp. 78-82 ◽

Cited By ~ 16

Author(s):

Rahul Aggarwal ◽

Xiao Wei ◽

Won Kim ◽

Eric J. Small ◽

Charles J. Ryan ◽

...

Keyword(s):

Prostate Cancer ◽

Positron Emission Tomography ◽

Tracer Uptake ◽

Emission Tomography ◽

Positron Emission Tomography Tracer ◽

Positron Emission ◽

Evaluation of [68Ga]Ga-PSMA-PET/CT in therapy response assessment of PSMA-targeted radionuclide therapy in patients with castration resistant prostate cancer

10.1055/s-0039-1683739 ◽

2019 ◽

Author(s):

J Kurth ◽

J Kretzschmar ◽

M Heuschkel ◽

G Kundt ◽

OW Hakenberg ◽

...

Keyword(s):

Prostate Cancer ◽

Radionuclide Therapy ◽

Therapy Response ◽

Response Assessment ◽

Targeted Radionuclide Therapy ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Psma Pet ◽

Pet Ct ◽

Therapy Response Assessment

68Ga–Prostate-Specific Membrane Antigen Uptake in a Malignant Pleural Effusion From Metastatic Prostate Cancer After Pleurodesis

Clinical Nuclear Medicine ◽

10.1097/rlu.0000000000002748 ◽

2019 ◽

Vol 44 (10) ◽

pp. 838-839

Author(s):

Christos Sachpekidis ◽

Ian Alberts ◽

Axel Rominger ◽

Ali Afshar-Oromieh

Keyword(s):

Prostate Cancer ◽

Pleural Effusion ◽

Malignant Pleural Effusion ◽

Antigen Uptake ◽

Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival

Nuclear Medicine Communications ◽

10.1097/mnm.0000000000001446 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Jens Kurth ◽

Justus Kretzschmar ◽

Hamzeh Aladwan ◽

Martin Heuschkel ◽

Anja Gummesson ◽

...

Keyword(s):

Prostate Cancer ◽

Therapy Response ◽

Response Assessment ◽

Radioligand Therapy ◽

Psma Pet ◽

Pet Ct ◽

Therapy Response Assessment